Concepts (191)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain Injuries, Traumatic | 17 | 2023 | 86 | 7.680 |
Why?
|
| Tranexamic Acid | 10 | 2023 | 25 | 4.360 |
Why?
|
| Antifibrinolytic Agents | 9 | 2023 | 30 | 4.170 |
Why?
|
| Blood Coagulation Disorders | 6 | 2023 | 63 | 2.380 |
Why?
|
| Wounds and Injuries | 9 | 2021 | 231 | 1.690 |
Why?
|
| Wounds, Nonpenetrating | 8 | 2023 | 92 | 1.620 |
Why?
|
| Intracranial Hemorrhages | 4 | 2023 | 120 | 1.520 |
Why?
|
| Wounds, Penetrating | 6 | 2019 | 46 | 1.280 |
Why?
|
| Fibrinolysis | 4 | 2023 | 35 | 1.230 |
Why?
|
| Hemorrhage | 6 | 2013 | 268 | 1.070 |
Why?
|
| Emergency Medical Services | 3 | 2023 | 209 | 1.060 |
Why?
|
| Fibrinogen | 2 | 2021 | 56 | 0.930 |
Why?
|
| Brain Injuries | 5 | 2023 | 161 | 0.910 |
Why?
|
| Glasgow Coma Scale | 5 | 2023 | 65 | 0.840 |
Why?
|
| Algorithms | 8 | 2018 | 1830 | 0.810 |
Why?
|
| Intracranial Hemorrhage, Traumatic | 1 | 2020 | 1 | 0.770 |
Why?
|
| Syndecan-1 | 1 | 2020 | 13 | 0.770 |
Why?
|
| Angiopoietin-2 | 1 | 2020 | 15 | 0.760 |
Why?
|
| Thrombelastography | 5 | 2021 | 47 | 0.720 |
Why?
|
| Multiple Trauma | 3 | 2018 | 34 | 0.700 |
Why?
|
| Blood Transfusion | 4 | 2013 | 157 | 0.670 |
Why?
|
| Adult | 27 | 2023 | 25648 | 0.610 |
Why?
|
| Thrombosis | 1 | 2019 | 296 | 0.580 |
Why?
|
| Disease Progression | 1 | 2021 | 1531 | 0.570 |
Why?
|
| Isotonic Solutions | 1 | 2016 | 17 | 0.560 |
Why?
|
| Blood Coagulation | 3 | 2021 | 91 | 0.550 |
Why?
|
| Sodium Chloride | 1 | 2016 | 88 | 0.550 |
Why?
|
| Spleen | 1 | 2017 | 430 | 0.550 |
Why?
|
| International Normalized Ratio | 2 | 2014 | 38 | 0.530 |
Why?
|
| Ethanol | 1 | 2018 | 249 | 0.530 |
Why?
|
| Biomarkers | 2 | 2023 | 1718 | 0.510 |
Why?
|
| Middle Aged | 19 | 2021 | 25028 | 0.510 |
Why?
|
| Injury Severity Score | 7 | 2018 | 111 | 0.500 |
Why?
|
| Humans | 47 | 2023 | 86643 | 0.490 |
Why?
|
| Trauma Centers | 7 | 2018 | 116 | 0.480 |
Why?
|
| Young Adult | 11 | 2020 | 5976 | 0.450 |
Why?
|
| Abbreviated Injury Scale | 4 | 2020 | 8 | 0.420 |
Why?
|
| Double-Blind Method | 3 | 2020 | 1823 | 0.410 |
Why?
|
| Blood Component Transfusion | 1 | 2011 | 13 | 0.410 |
Why?
|
| Male | 23 | 2023 | 40965 | 0.410 |
Why?
|
| Female | 24 | 2021 | 44532 | 0.410 |
Why?
|
| Abdominal Injuries | 3 | 2018 | 39 | 0.400 |
Why?
|
| Traumatology | 2 | 2022 | 27 | 0.340 |
Why?
|
| Aged | 11 | 2021 | 18415 | 0.320 |
Why?
|
| Retrospective Studies | 13 | 2022 | 8489 | 0.320 |
Why?
|
| Emergency Service, Hospital | 4 | 2020 | 484 | 0.310 |
Why?
|
| Prospective Studies | 6 | 2021 | 4213 | 0.300 |
Why?
|
| Heart | 1 | 2010 | 539 | 0.300 |
Why?
|
| Diaphragm | 2 | 2018 | 50 | 0.290 |
Why?
|
| Thoracotomy | 2 | 2018 | 58 | 0.290 |
Why?
|
| Survival Rate | 6 | 2013 | 1863 | 0.280 |
Why?
|
| Colon | 2 | 2019 | 496 | 0.260 |
Why?
|
| Thoracic Injuries | 2 | 2015 | 32 | 0.260 |
Why?
|
| Predictive Value of Tests | 5 | 2020 | 1673 | 0.260 |
Why?
|
| Clinical Decision-Making | 4 | 2018 | 257 | 0.230 |
Why?
|
| Infusions, Intravenous | 2 | 2020 | 429 | 0.220 |
Why?
|
| Time-to-Treatment | 2 | 2020 | 98 | 0.220 |
Why?
|
| Mass Casualty Incidents | 1 | 2022 | 12 | 0.210 |
Why?
|
| Head Injuries, Penetrating | 1 | 2023 | 54 | 0.210 |
Why?
|
| Shock | 1 | 2022 | 42 | 0.210 |
Why?
|
| Erythrocyte Count | 2 | 2011 | 23 | 0.210 |
Why?
|
| Blood Coagulation Tests | 1 | 2021 | 35 | 0.200 |
Why?
|
| Platelet Count | 2 | 2011 | 92 | 0.200 |
Why?
|
| Adolescent | 4 | 2020 | 8981 | 0.200 |
Why?
|
| Health Services Research | 1 | 2022 | 136 | 0.200 |
Why?
|
| Survival Analysis | 3 | 2020 | 1538 | 0.190 |
Why?
|
| Patient Acuity | 1 | 2020 | 32 | 0.190 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2020 | 58 | 0.190 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2020 | 63 | 0.180 |
Why?
|
| Fracture Fixation | 2 | 2017 | 31 | 0.180 |
Why?
|
| Intracranial Pressure | 2 | 2023 | 77 | 0.180 |
Why?
|
| Brain Diseases | 1 | 2020 | 180 | 0.170 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2020 | 176 | 0.170 |
Why?
|
| Wounds, Stab | 1 | 2018 | 9 | 0.170 |
Why?
|
| Peritoneum | 1 | 2019 | 57 | 0.170 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2018 | 36 | 0.170 |
Why?
|
| Neuropsychological Tests | 1 | 2020 | 502 | 0.160 |
Why?
|
| Aged, 80 and over | 2 | 2019 | 6509 | 0.160 |
Why?
|
| Rectum | 1 | 2018 | 146 | 0.160 |
Why?
|
| Occupational Exposure | 1 | 2018 | 80 | 0.150 |
Why?
|
| Rib Fractures | 1 | 2017 | 8 | 0.150 |
Why?
|
| Fever | 1 | 2018 | 125 | 0.150 |
Why?
|
| Clinical Protocols | 1 | 2017 | 156 | 0.140 |
Why?
|
| United States | 5 | 2022 | 6672 | 0.140 |
Why?
|
| Pelvic Bones | 1 | 2016 | 44 | 0.140 |
Why?
|
| Follow-Up Studies | 3 | 2020 | 3640 | 0.140 |
Why?
|
| Duodenum | 1 | 2015 | 100 | 0.130 |
Why?
|
| Esophagus | 1 | 2015 | 102 | 0.130 |
Why?
|
| Fractures, Bone | 1 | 2016 | 131 | 0.130 |
Why?
|
| Logistic Models | 3 | 2012 | 1186 | 0.120 |
Why?
|
| Heparin, Low-Molecular-Weight | 1 | 2012 | 29 | 0.110 |
Why?
|
| Kidney | 1 | 2018 | 1241 | 0.110 |
Why?
|
| Enteral Nutrition | 1 | 2012 | 102 | 0.110 |
Why?
|
| Treatment Outcome | 6 | 2020 | 7993 | 0.110 |
Why?
|
| Intestinal Obstruction | 1 | 2012 | 88 | 0.100 |
Why?
|
| Cerebral Hemorrhage | 1 | 2014 | 325 | 0.100 |
Why?
|
| Medical Futility | 1 | 2011 | 28 | 0.100 |
Why?
|
| Ultrasonography, Doppler, Duplex | 1 | 2011 | 40 | 0.100 |
Why?
|
| Patient Selection | 1 | 2015 | 685 | 0.100 |
Why?
|
| Registries | 1 | 2015 | 702 | 0.100 |
Why?
|
| Time Factors | 3 | 2014 | 5210 | 0.100 |
Why?
|
| Lower Extremity | 1 | 2011 | 84 | 0.100 |
Why?
|
| Blood Volume Determination | 1 | 2010 | 14 | 0.090 |
Why?
|
| Central Venous Pressure | 1 | 2010 | 26 | 0.090 |
Why?
|
| Venous Thromboembolism | 1 | 2012 | 153 | 0.090 |
Why?
|
| Fluid Therapy | 1 | 2010 | 50 | 0.090 |
Why?
|
| Cardiac Output | 1 | 2010 | 156 | 0.090 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2010 | 107 | 0.090 |
Why?
|
| Inflammation | 1 | 2015 | 920 | 0.090 |
Why?
|
| Resuscitation | 3 | 2016 | 100 | 0.090 |
Why?
|
| Point-of-Care Systems | 1 | 2010 | 141 | 0.090 |
Why?
|
| Monitoring, Physiologic | 2 | 2023 | 268 | 0.080 |
Why?
|
| Venous Thrombosis | 1 | 2011 | 243 | 0.080 |
Why?
|
| Pulmonary Artery | 1 | 2010 | 306 | 0.080 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2009 | 112 | 0.080 |
Why?
|
| Sex Factors | 1 | 2011 | 1054 | 0.080 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2018 | 2601 | 0.080 |
Why?
|
| Stroke Volume | 1 | 2010 | 456 | 0.080 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2009 | 208 | 0.070 |
Why?
|
| Ventricular Function, Left | 1 | 2010 | 592 | 0.070 |
Why?
|
| Risk Factors | 5 | 2018 | 5417 | 0.070 |
Why?
|
| Trauma Severity Indices | 2 | 2018 | 41 | 0.070 |
Why?
|
| Cohort Studies | 1 | 2011 | 2767 | 0.060 |
Why?
|
| Decision Support Techniques | 2 | 2015 | 160 | 0.060 |
Why?
|
| Colostomy | 2 | 2019 | 13 | 0.060 |
Why?
|
| Comparative Effectiveness Research | 1 | 2023 | 53 | 0.050 |
Why?
|
| Death | 1 | 2023 | 73 | 0.050 |
Why?
|
| Cecostomy | 1 | 2002 | 1 | 0.050 |
Why?
|
| Anus, Imperforate | 1 | 2002 | 11 | 0.050 |
Why?
|
| Tomography | 1 | 2022 | 20 | 0.050 |
Why?
|
| Organizational Objectives | 1 | 2022 | 27 | 0.050 |
Why?
|
| Academies and Institutes | 1 | 2022 | 31 | 0.050 |
Why?
|
| Delphi Technique | 1 | 2022 | 80 | 0.050 |
Why?
|
| alpha-2-Antiplasmin | 1 | 2020 | 6 | 0.050 |
Why?
|
| Lumbar Vertebrae | 1 | 2002 | 148 | 0.050 |
Why?
|
| Fibrinolysin | 1 | 2020 | 26 | 0.050 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2020 | 28 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2018 | 1805 | 0.050 |
Why?
|
| Hospital Mortality | 2 | 2013 | 349 | 0.050 |
Why?
|
| Injections, Intravenous | 1 | 2020 | 244 | 0.050 |
Why?
|
| Incidence | 2 | 2015 | 1577 | 0.040 |
Why?
|
| Brain | 2 | 2023 | 2216 | 0.040 |
Why?
|
| Anticoagulants | 2 | 2012 | 408 | 0.040 |
Why?
|
| Research Design | 1 | 2022 | 594 | 0.040 |
Why?
|
| Patient Admission | 1 | 2018 | 112 | 0.040 |
Why?
|
| Hypotension | 1 | 2018 | 70 | 0.040 |
Why?
|
| Hematoma | 1 | 2018 | 104 | 0.040 |
Why?
|
| Physical Examination | 1 | 2018 | 149 | 0.040 |
Why?
|
| Anastomosis, Surgical | 1 | 2019 | 267 | 0.040 |
Why?
|
| Health Surveys | 1 | 2018 | 239 | 0.040 |
Why?
|
| Shock, Hemorrhagic | 1 | 2016 | 11 | 0.040 |
Why?
|
| Phenotype | 1 | 2023 | 2378 | 0.040 |
Why?
|
| Health Personnel | 1 | 2018 | 202 | 0.030 |
Why?
|
| Practice Management | 1 | 2015 | 1 | 0.030 |
Why?
|
| Pain Management | 1 | 2017 | 127 | 0.030 |
Why?
|
| Unnecessary Procedures | 1 | 2015 | 51 | 0.030 |
Why?
|
| Critical Care | 1 | 2018 | 370 | 0.030 |
Why?
|
| Risk Assessment | 2 | 2012 | 2261 | 0.030 |
Why?
|
| Guidelines as Topic | 1 | 2015 | 162 | 0.030 |
Why?
|
| Cytokines | 1 | 2018 | 776 | 0.030 |
Why?
|
| Hemodynamics | 1 | 2016 | 710 | 0.030 |
Why?
|
| Intra-Abdominal Hypertension | 1 | 2012 | 5 | 0.030 |
Why?
|
| Peritonitis | 1 | 2012 | 29 | 0.030 |
Why?
|
| Laparotomy | 1 | 2012 | 59 | 0.030 |
Why?
|
| Safety Management | 1 | 2012 | 56 | 0.030 |
Why?
|
| Evidence-Based Medicine | 1 | 2015 | 429 | 0.030 |
Why?
|
| Hospitalization | 1 | 2018 | 849 | 0.030 |
Why?
|
| Heart Arrest | 1 | 2015 | 265 | 0.030 |
Why?
|
| Primary Prevention | 1 | 2012 | 85 | 0.030 |
Why?
|
| Oregon | 1 | 2011 | 26 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2015 | 814 | 0.020 |
Why?
|
| Reference Values | 1 | 2012 | 674 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2013 | 859 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2013 | 695 | 0.020 |
Why?
|
| Intestine, Small | 1 | 2012 | 303 | 0.020 |
Why?
|
| Patient Discharge | 1 | 2012 | 300 | 0.020 |
Why?
|
| Aortography | 1 | 2009 | 63 | 0.020 |
Why?
|
| Intestines | 1 | 2012 | 411 | 0.020 |
Why?
|
| Low Back Pain | 1 | 2009 | 40 | 0.020 |
Why?
|
| ROC Curve | 1 | 2011 | 752 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2019 | 2207 | 0.020 |
Why?
|
| Societies, Medical | 1 | 2012 | 572 | 0.020 |
Why?
|
| Critical Illness | 1 | 2011 | 294 | 0.020 |
Why?
|
| Abdominal Pain | 1 | 2009 | 137 | 0.020 |
Why?
|
| Intensive Care Units | 1 | 2011 | 373 | 0.020 |
Why?
|
| Contrast Media | 1 | 2012 | 1078 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2011 | 1036 | 0.010 |
Why?
|
| Prognosis | 1 | 2011 | 3679 | 0.010 |
Why?
|
| Enema | 1 | 2002 | 37 | 0.010 |
Why?
|
| Fecal Incontinence | 1 | 2002 | 57 | 0.010 |
Why?
|
| Infant | 1 | 2002 | 3046 | 0.010 |
Why?
|